Vulnerability Description
The backend database of the Philips DoseWise Portal application versions 1.1.7.333 and 2.1.1.3069 uses hard-coded credentials for a database account with privileges that can affect confidentiality, integrity, and availability of the database. For an attacker to exploit this vulnerability, elevated privileges are first required for an attacker to access the web application backend system files that contain the hard-coded credentials. Successful exploitation may allow a remote attacker to gain access to the database of the DWP application, which contains PHI. CVSS v3 base score: 9.1, CVSS vector string: AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H.
CVSS Score
CRITICAL
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Philips | Dosewise | 1.1.7.333 |
Related Weaknesses (CWE)
References
- http://www.philips.com/productsecurityVendor Advisory
- http://www.securityfocus.com/bid/100471Third Party AdvisoryVDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-229-01Third Party AdvisoryUS Government Resource
- http://www.philips.com/productsecurityVendor Advisory
- http://www.securityfocus.com/bid/100471Third Party AdvisoryVDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-229-01Third Party AdvisoryUS Government Resource
FAQ
What is CVE-2017-9656?
CVE-2017-9656 is a vulnerability with a CVSS score of 9.1 (CRITICAL). The backend database of the Philips DoseWise Portal application versions 1.1.7.333 and 2.1.1.3069 uses hard-coded credentials for a database account with privileges that can affect confidentiality, in...
How severe is CVE-2017-9656?
CVE-2017-9656 has been rated CRITICAL with a CVSS base score of 9.1/10. This is considered a critical vulnerability requiring immediate attention.
Is there a patch for CVE-2017-9656?
Check the references section above for vendor advisories and patch information. Affected products include: Philips Dosewise.